A comparison of glide force characteristics between 2 prefilled insulin lispro pens.
| Autor: | Rees TM; Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN, USA rees_tina_marie@lilly.com., Lennartz AH; Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN, USA., Ignaut DA; Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of diabetes science and technology [J Diabetes Sci Technol] 2015 Mar; Vol. 9 (2), pp. 316-9. Date of Electronic Publication: 2015 Jan 14. |
| DOI: | 10.1177/1932296814567533 |
| Abstrakt: | Glide force, average glide force, and glide force variability of the insulin lispro 200 units/mL pen (Eli Lilly and Company, Indianapolis, IN, USA) were compared to the Humalog KwikPen 100 units/mL pen (hereafter, KwikPen; Eli Lilly and Company, Indianapolis, IN, USA). Data were collected on 2 doses, 2 injection speeds, and 2 needle types. Insulin lispro 200 units/mL pen showed significantly lower maximum glide force, average glide force, and glide force variability than the KwikPen across all combinations of dose size, dose speed, and needle type. The lower glide force observed with the insulin lispro 200 units/mL pen offers another treatment option for patients with type 1 or type 2 diabetes who require greater than 20 units of mealtime insulin daily. (© 2015 Diabetes Technology Society.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|